Yangyi Bao

501 total citations
17 papers, 346 citations indexed

About

Yangyi Bao is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yangyi Bao has authored 17 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Yangyi Bao's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (5 papers). Yangyi Bao is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (5 papers). Yangyi Bao collaborates with scholars based in China, United States and Taiwan. Yangyi Bao's co-authors include Qiao Li, Lin Yang, Alfred E. Chang, Fu Dai, Xiang Sun, Shiang Huang, Yi Wang, Xiaowen Tang, Xuejun Zhu and Lin Lü and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Yangyi Bao

17 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangyi Bao China 9 229 220 90 42 33 17 346
Julie Cramer United States 2 264 1.2× 153 0.7× 97 1.1× 29 0.7× 14 0.4× 3 321
Huayu Huang United States 3 312 1.4× 202 0.9× 126 1.4× 33 0.8× 14 0.4× 3 393
Barath Shreeder United States 6 276 1.2× 279 1.3× 76 0.8× 36 0.9× 10 0.3× 8 381
Ian L. Linde United States 9 220 1.0× 299 1.4× 160 1.8× 40 1.0× 15 0.5× 11 458
Abraham Sachs United States 4 285 1.2× 244 1.1× 145 1.6× 80 1.9× 20 0.6× 4 381
Nicholas Papadopoulos United States 7 237 1.0× 155 0.7× 137 1.5× 27 0.6× 12 0.4× 11 328
Jitske van den Bulk Netherlands 7 232 1.0× 196 0.9× 144 1.6× 24 0.6× 13 0.4× 7 383
Sundee Dees United States 6 211 0.9× 142 0.6× 105 1.2× 53 1.3× 8 0.2× 7 323
Taylor Kalomeris United States 5 178 0.8× 131 0.6× 186 2.1× 75 1.8× 18 0.5× 12 399
Alois Walder Austria 4 166 0.7× 228 1.0× 86 1.0× 54 1.3× 49 1.5× 6 377

Countries citing papers authored by Yangyi Bao

Since Specialization
Citations

This map shows the geographic impact of Yangyi Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangyi Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangyi Bao more than expected).

Fields of papers citing papers by Yangyi Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangyi Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangyi Bao. The network helps show where Yangyi Bao may publish in the future.

Co-authorship network of co-authors of Yangyi Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Yangyi Bao. A scholar is included among the top collaborators of Yangyi Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangyi Bao. Yangyi Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tao, Qianshan, et al.. (2023). [miR-181b-5p promotes cell proliferation and induces apoptosis in human acute myeloid leukemia by targeting PAX9].. PubMed. 39(12). 1074–1082. 2 indexed citations
2.
Xia, Leiming, Lu Wen, You Qin, et al.. (2021). HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells. Cell chemical biology. 28(5). 610–624.e5. 10 indexed citations
3.
Li, Qiao, Yi Wang, Ming Lin, et al.. (2019). Abstract A014: Phase I clinical trial with PD-1/MUC1 CAR-pNK92 immunotherapy. Cancer Immunology Research. 7(2_Supplement). A014–A014. 17 indexed citations
4.
Xia, Leiming, Yi Wang, Li Tan, et al.. (2019). The clinical study on treatment of CD19‐directed chimeric antigen receptor‐modified T cells in a case of refractory Richter syndrome. Cancer Medicine. 8(6). 2930–2941. 4 indexed citations
5.
Sun, Xiang, et al.. (2018). Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling. Medical Science Monitor. 24. 3193–3203. 11 indexed citations
6.
Yuan, Yu, Jialu Li, Xuejun Zhu, et al.. (2017). Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential. International Journal of Nanomedicine. Volume 12. 1969–1983. 55 indexed citations
7.
Chen, Ying, Fengtao You, Licui Jiang, et al.. (2017). Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody. Oncotarget. 8(23). 37128–37139. 37 indexed citations
8.
Xia, Leiming, Qian Chen, Qiao Li, et al.. (2017). Abstract CT041: The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter Syndrome. Cancer Research. 77(13_Supplement). CT041–CT041. 3 indexed citations
9.
Li, Juan, Yi Wang, Liu Liu, Yuan Yuan, & Yangyi Bao. (2017). [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].. SHILAP Revista de lepidopterología. 20(2). 80–87. 3 indexed citations
10.
Hu, Yangyang, Lin Lü, Yang Xia, et al.. (2016). Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. Cancer Research. 76(16). 4661–4672. 67 indexed citations
11.
Yang, Xia, Huimin Tao, Yangyang Hu, et al.. (2016). IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways. Oncotarget. 7(37). 60461–60474. 28 indexed citations
12.
Li, Hongxia, Juan Li, Leiming Xia, et al.. (2016). Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo. Medical Science Monitor. 22. 2624–2634. 13 indexed citations
13.
Gong, Li, Yi Wang, Liu Liu, et al.. (2015). [Mechanism of Killing Effect of Thioridazine on Human Lung Cancer PC9 Cells].. SHILAP Revista de lepidopterología. 18(12). 727–33. 6 indexed citations
14.
15.
Xia, Yang, Huimin Tao, Yangyang Hu, et al.. (2015). Abstract 1340: Antitumor effector B cells directly kill tumor cells involving the CXCL12/CXCR4 pathway and their therapeutic efficacy is enhanced by IL-2. Cancer Research. 75(15_Supplement). 1340–1340. 1 indexed citations
16.
Tao, Huimin, Lin Lü, Fu Dai, et al.. (2014). Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL‐10. European Journal of Immunology. 45(4). 999–1009. 87 indexed citations
17.
Bao, Yangyi. (2012). Clinical research of advanced non-small cell lung cancer patients treated with CIK cell combined with chemotherapy. Anhui Medical and Pharmaceutical Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Cramer Breakdown of academic impact, for papers by Huayu Huang Breakdown of academic impact, for papers by Barath Shreeder Breakdown of academic impact, for papers by Ian L. Linde Breakdown of academic impact, for papers by Abraham Sachs Breakdown of academic impact, for papers by Nicholas Papadopoulos Breakdown of academic impact, for papers by Jitske van den Bulk Breakdown of academic impact, for papers by Sundee Dees Breakdown of academic impact, for papers by Taylor Kalomeris Breakdown of academic impact, for papers by Alois Walder
Rankless by CCL
2026